Form D · Pharmaceuticals

CARDEAS PHARMA Corp

Seattle, WA · CIK 0001497414

Offering snapshot reported Apr 9, 2015 · SEC filing

Reported sold
$37.5M
Offering amount: $37.5M
Investors reported
21
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 17, 2013
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$18.8M$37.5MMay 23, 2013: $34,000,000.00May 23, 2013Apr 9, 2015: $37,500,000.00Apr 9, 2015

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$34,000,000 → $37,500,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 9, 2015Amendment$37,500,000$3,500,000vs May 23, 201321SEC filing
May 23, 2013Initial$34,000,000No comparison21SEC filing
Sep 27, 2012Amendment$10,527,201$2,991,213vs Mar 16, 201212SEC filing
Mar 16, 2012Amendment$7,535,988$1,635,993vs Dec 30, 201110SEC filing
Dec 30, 2011Initial$5,899,995No comparison5SEC filing
Feb 22, 2011Initial$1,001,523No comparison18SEC filing
Aug 10, 2010Initial$20,100No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-196992

Source: Form D, filed Apr 9, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Aaron Davidson Director
Robert De Gavre Director
Stephen Graham Executive
Kevin Kinsella Director
Peter Moldt Director
A. Bruce Montgomery Director, Executive, Promoter
Anthony Scullion Director
Melissa Yeager Executive, Promoter

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
2025 1 St Avenue Suite 1200
Seattle, WA, 98121